Screening for osteoporosis: U.S. preventive services task force recommendation statement

Annals of Internal Medicine

Volumn 154, Issue 5, 2011, Pages 356-365

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; PARATHYROID HORMONE; RALOXIFENE; VITAMIN D;

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; UNITED STATES;

EID: 79952230364     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-154-5-201103010-00307     Document Type: Article

References (17)

1. Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998;280:2077-82. [PMID: 9875874]
2. Nelson HD, Haney EM, Dana T, Bougatsos C, Chou R. Screening for osteoporosis: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2010;153:99-111. [PMID: 20621892]
3. Nelson HD, Haney E, Dana T, Chou R. Screening for Osteoporosis in Men and Women: Systematic Evidence Update for the U.S. Preventive Services Task Force. Evidence Synthesis No. 77. AHRQ Publication No. 10-05145-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2010.
4. Hillier TA, Stone KL, Bauer DC, Rizzo JH, Pedula KL, Cauley JA, et al. Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures. Arch Intern Med. 2007;167:155-60. [PMID: 17242316]
5. U.S. Department of Health and Human Services. Bone Health and Osteo- porosis: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services Office of the Surgeon General; 2004.
6. Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18: 1033-46. [PMID: 17323110]
7. U.S. Preventive Services Task Force. Screening for Osteoporosis in Postmeno- pausal Women: Recommendations and Rationale. Rockville, MD: Agency for Healthcare Research and Quality; 2002.
8. Nayak S, Olkin I, Liu H, Grabe M, Gould MK, Allen IE, et al. Meta- analysis: accuracy of quantitative ultrasound for identifying patients with osteo- porosis. Ann Intern Med. 2006;144:832-41. [PMID: 16754925]
9. Nelson HD, Fu R, Griffin JC, Nygren P, Smith ME, Humphrey L. Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer. Ann Intern Med. 2009;151:703-15, W-226-35. [PMID: 19920271]
10. Sawka AM, Papaioannou A, Adachi JD, Gafni A, Hanley DA, Thabane L. Does alendronate reduce the risk of fracture in men? A meta-analysis incorporat- ing prior knowledge of anti-fracture efficacy in women. BMC Musculoskelet Disord. 2005;6:39. [PMID: 16008835]
11. Orwoll ES, Scheele WH, Paul S, Adami S, Syversen U, Diez-Perez A, et al. The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res. 2003;18:9-17. [PMID: 12510800]
12. Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM. Use of alendro- nate and risk of incident atrial fibrillation in women. Arch Intern Med. 2008; 168:826-31. [PMID: 18443257]
13. Sørensen HT, Christensen S, Mehnert F, Pedersen L, Chapurlat RD, Cummings SR, et al. Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study. BMJ. 2008;336: 813-6. [PMID: 18334527]
14. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Founda- tion; 2008.
15. Johnell O, Hertzman P. What evidence is there for the prevention and screening of osteoporosis? Copenhagen: World Health Organization Regional Office for Europe (Health Evidence Network); 2006. Accessed at www.euro.who.int/document/e88668.pdf on 7 January 2011.
16. Qaseem A, Snow V, Shekelle P, Hopkins R Jr, Forciea MA, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008;148:680-4. [PMID: 18458281]
17. American College of Obstetricians and Gynecologists. Osteoporosis. Washington, DC: American College of Obstetricians and Gynecologists; 2004.